Matches in Wikidata for { <http://www.wikidata.org/entity/Q85322632> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q85322632 description "article scientifique publié en 2014" @default.
- Q85322632 description "artículu científicu espublizáu en setiembre de 2014" @default.
- Q85322632 description "scientific article published on 13 September 2014" @default.
- Q85322632 description "wetenschappelijk artikel" @default.
- Q85322632 description "наукова стаття, опублікована у вересні 2014" @default.
- Q85322632 name "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 name "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 type Item @default.
- Q85322632 label "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 label "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 prefLabel "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 prefLabel "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 P1433 Q85322632-FA274AC1-735B-4891-B014-35F29680C8EF @default.
- Q85322632 P1476 Q85322632-EAAC681D-0677-479D-AC4F-D2C712012275 @default.
- Q85322632 P2093 Q85322632-5BC0C5C5-97F0-4C28-8F52-72E46E2285C3 @default.
- Q85322632 P2093 Q85322632-6C6C14CC-42A0-4144-AA9D-7D215F762476 @default.
- Q85322632 P2093 Q85322632-A0DD58A6-55D8-4871-A9ED-C888935E534C @default.
- Q85322632 P2093 Q85322632-A19E77B0-DAA4-4990-A970-69947D461970 @default.
- Q85322632 P304 Q85322632-F31A5970-24FF-45F1-A593-6DD833D3FEC6 @default.
- Q85322632 P31 Q85322632-C38FC28F-B637-411F-91BD-49DE76C0C9FB @default.
- Q85322632 P356 Q85322632-C35507F9-CCFB-4B9A-B998-DE25EC5067F3 @default.
- Q85322632 P433 Q85322632-E2AF1B0C-40A6-4510-A470-F91041A17CBA @default.
- Q85322632 P478 Q85322632-40A7DAFC-5036-4424-939C-B29DE415103A @default.
- Q85322632 P577 Q85322632-4659282F-AD89-4101-89C7-277AF26D4676 @default.
- Q85322632 P698 Q85322632-AEA3736F-A4A5-4FE7-BF0E-BB84A99818D8 @default.
- Q85322632 P921 Q85322632-0E519C60-5BC2-4AA3-92C8-CF1C12E88F8A @default.
- Q85322632 P921 Q85322632-EF95FF46-195D-4BB0-AA50-C6157ABD1539 @default.
- Q85322632 P356 J.OPHTHA.2014.07.041 @default.
- Q85322632 P698 25227499 @default.
- Q85322632 P1433 Q7098109 @default.
- Q85322632 P1476 "Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol" @default.
- Q85322632 P2093 "Karina Berg" @default.
- Q85322632 P2093 "Leiv Sandvik" @default.
- Q85322632 P2093 "Ragnheiður Bragadóttir" @default.
- Q85322632 P2093 "Terje R Pedersen" @default.
- Q85322632 P304 "146-152" @default.
- Q85322632 P31 Q13442814 @default.
- Q85322632 P356 "10.1016/J.OPHTHA.2014.07.041" @default.
- Q85322632 P433 "1" @default.
- Q85322632 P478 "122" @default.
- Q85322632 P577 "2014-09-13T00:00:00Z" @default.
- Q85322632 P698 "25227499" @default.
- Q85322632 P921 Q27429789 @default.
- Q85322632 P921 Q413299 @default.